These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30546600)

  • 1. Effective cascade screening through identification of a mutation in
    Bailey C; Blair E; Garratt C; Newman WG
    J Cardiol Cases; 2016 Jan; 13(1):9-13. PubMed ID: 30546600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of RYR2 Mutation Causing Sudden Cardiac Arrest Due to Catecholaminergic Polymorphic Ventricular Tachycardia.
    Vemireddy LP; Aqeel A; Ying GW; Majlesi D; Woo V
    Cureus; 2021 Feb; 13(2):e13417. PubMed ID: 33763313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BASIC AND CLINICAL INSIGHTS IN CATECHOLAMINERGIC (FAMILIAL) POLYMORPHIC VENTRICULAR TACHYCARDIA.
    Márquez MF; Totomoch-Serra A; Rueda A; Avelino-Cruz JE; Gallegos-Cortez A
    Rev Invest Clin; 2019; 71(4):226-236. PubMed ID: 31448784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the
    Stępień-Wojno M; Ponińska J; Biernacka EK; Foss-Nieradko B; Chwyczko T; Syska P; Płoski R; Bilińska ZT
    Diagnostics (Basel); 2020 Jun; 10(7):. PubMed ID: 32605058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.
    Tester DJ; Ackerman JP; Giudicessi JR; Ackerman NC; Cerrone M; Delmar M; Ackerman MJ
    JACC Clin Electrophysiol; 2019 Jan; 5(1):120-127. PubMed ID: 30678776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
    J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catecholaminergic polymorphic ventricular tachycardia; possible diagnosis in cases of syncope and sudden death of family members].
    Lieve KV; Wilde AA; van der Werf C
    Ned Tijdschr Geneeskd; 2015; 159():A8205. PubMed ID: 25650029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children].
    Ge HY; Li XM; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li MT
    Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):926-931. PubMed ID: 29262473
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
    Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
    Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.
    Laitinen PJ; Swan H; Piippo K; Viitasalo M; Toivonen L; Kontula K
    Ann Med; 2004; 36 Suppl 1():81-6. PubMed ID: 15176428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening in sudden cardiac death in the young can save future lives.
    Stattin EL; Westin IM; Cederquist K; Jonasson J; Jonsson BA; Mörner S; Norberg A; Krantz P; Wisten A
    Int J Legal Med; 2016 Jan; 130(1):59-66. PubMed ID: 26228265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.
    Andrsova I; Valaskova I; Kubus P; Vit P; Gaillyova R; Kadlecova J; Manouskova L; Novotny T
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):798-803. PubMed ID: 22519458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current topics in catecholaminergic polymorphic ventricular tachycardia.
    Sumitomo N
    J Arrhythm; 2016 Oct; 32(5):344-351. PubMed ID: 27761157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
    J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.